PAR-25-079-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the "Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)" federal grant opportunity. The objective is to stimulate the translation of scientific discoveries and engineering developments in imaging, data science, and/or spectroscopic technologies into methods or tools for understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other diseases.

The funding opportunity is being offered by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services National Institutes of Health. The eligible applicant types include higher education institutions (public and private), small businesses, nonprofits, tribal governments, and other organizations. The funding activity categories are education and health. The CFDA numbers are 93.394 (Cancer Detection and Diagnosis Research) and 93.395 (Cancer Treatment Research). The NOFO does not specify award dates, values, or response deadlines.